Editorial content Premium Content
CNS

Advances in neuroscience and surging markets could signal deal spree

After a period of setbacks and the exodus of high-profile companies from neuroscience research and development, industry leaders predict a rebound in neuroscience investment and deal activity in areas such as pain.

Go to the profile of Raveena Bhambra
Sep 24, 2015
2
0

Please sign in or register for FREE

Register to BioPharma Dealmakers

From the publishers of Nature, the BioPharma Dealmakers website brings together life sciences companies and individuals looking to identify and attract partners and dealmaking opportunities. It provides insights into dealmaking trends from BioPharma Dealmakers Editors, profiles from companies looking to partner, tools for networking and sharing knowledge, and the opportunity for sponsoring companies to showcase their expertise. BioPharma Dealmakers is THE destination for partnering professionals looking to make connections and get the latest on their industry.

Register

No comments yet.